NEW YORK (GenomeWeb News) — Ciphergen has hired European international standards consulting company Emergo to help it win CE Mark clearance for its ovarian cancer in vitro diagnostic, the company said today.
 
The company said it also is preparing a clinical trial toward gaining clearance with the US Food and Drug Administration.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.